Meritage Portfolio Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-75,987
Closed -$4.79M 324
2025
Q3
$4.79M Buy
75,987
+28,509
+60% +$1.99M 0.32% 92
2025
Q2
$3.54M Buy
47,478
+271
+0.6% +$21.3K 0.22% 124
2025
Q1
$4.16M Sell
47,207
-445
-0.9% -$42K 0.28% 109
2024
Q4
$4.35M Sell
47,652
-1,589
-3% -$163K 0.27% 108
2024
Q3
$5.51M Sell
49,241
-992
-2% -$99.2K 0.34% 91
2024
Q2
$4.92M Buy
+50,233
New +$4.98M 0.31% 96
2020
Q2
Sell
-30,102
Closed -$1.4M 214
2020
Q1
$1.4M Sell
30,102
-536
-2% -$34.4K 0.19% 131
2019
Q4
$2.43M Buy
30,638
+413
+1% +$31.8K 0.21% 161
2019
Q3
$2.23M Buy
+30,225
New +$2.17M 0.21% 162

Other funds holding EMN

Meritage Portfolio Management's EMN Position: Q4 2025 in Review

Meritage Portfolio Management sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 75,987 shares — an estimated $4.79M sold.

Meritage Portfolio Management first reported a position in EMN in Q3 2019 and held it in 9 quarters. The position peaked at $5.51M in Q3 2024. 633 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Meritage Portfolio Management reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Meritage Portfolio Management sold 75,987 Eastman Chemical shares in Q4 2025, an estimated $4.79M.
  • Meritage Portfolio Management first reported a position in Eastman Chemical in Q3 2019 and held it in 9 quarters.
  • Meritage Portfolio Management's Eastman Chemical position peaked at $5.51M in Q3 2024.
  • 633 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.